^
BIOMARKER:

FGFR2 amplification

i
Other names: FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2
Entrez ID:
FGFR2 amplification
Gastric Cancer
TAS 120
Sensitive: C2 – Inclusion Criteria
FGFR2 amplification
Breast Cancer
TAS 120
Sensitive: C2 – Inclusion Criteria
FGFR2 amplification
Cholangiocarcinoma
ARQ 087
Sensitive: C2 – Inclusion Criteria
FGFR2 amplification
Breast Cancer
infigratinib
Sensitive: C2 – Inclusion Criteria
FGFR2 amplification
Gastric Cancer
AMG 552
Sensitive: C2 – Inclusion Criteria
FGFR2 amplification
GastroEsophageal Cancer
ABSK-091
Sensitive: C3 – Early Trials
FGFR2 amplification
Gastric Cancer
Debio 1347
Resistant: C3 – Early Trials
FGFR2 amplification
Breast Cancer
TKI258
Sensitive: C3 – Early Trials
FGFR2 amplification
Breast Cancer
Debio 1347
Sensitive: C3 – Early Trials
FGFR2 amplification
Gastric Cancer
FGFR inhibitor
Sensitive: C3 – Early Trials
FGFR2 amplification
Breast Cancer
ponatinib
Sensitive: D – Preclinical
FGFR2 amplification
Gastric Adenocarcinoma
TAS 120
Sensitive: D – Preclinical
FGFR2 amplification
CRC
eFT226
Sensitive: D – Preclinical
FGFR2 amplification
Gastric Cancer
erdafitinib
Sensitive: D – Preclinical
FGFR2 amplification
CRC
ponatinib
Sensitive: D – Preclinical
FGFR2 amplification
NSCLC
eFT226
Sensitive: D – Preclinical
FGFR2 amplification
Gastric Cancer
ponatinib
Sensitive: D – Preclinical
FGFR2 amplification
Breast Cancer
eFT226
Sensitive: D – Preclinical
FGFR2 amplification
Gastric Adenocarcinoma
nintedanib
Sensitive: D – Preclinical